As of May 22
| -0.01 / -0.21%|
The 2 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 9.75, with a high estimate of 12.00 and a low estimate of 7.50. The median estimate represents a +105.70% increase from the last price of 4.74.
The current consensus among 3 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.